USPTO serial 77780292
GENE CHOICE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DAWE III, WILLIAM H
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with GENE CHOICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa N. Kaufman
LISA N. KAUFMAN ROTHSTEIN ROSENFELDT ADLER401 E LAS OLAS BLVD STE 1650FORT LAUDERDALE, FL 33301-4252UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Antimicrobial cells; Full line of Molecular Biology Kits and Reagents for Genetic Research including, DNA Polymerase; DNA Polymerase Reaction Buffers in the nature of buffers used for amplification of DNA; Reaction mixes for running Polymerase Chain Reactions comprising DNA Polymerase, dNTP and Red Dye; DNA Polymerase, namely, Enzymes with DNA Polymerase and Proof-reading Exonnuclease activities; Buffer Optimization Kits comprising standard buffers, ammonium buffers and combination buffers used for finding optimal solutions for Polymerase Chain Reactions; Enhancer Optimization Kits for selecting additives for templates comprising reactions of enhancer solutions for testing to determine improvements in Polymerase Chain Reactions; Nucleotides; dNTP Mixes; dNTP Solutions for use in DNA polymerization reactions, DNA-labelling and sequencing processes; DNA ladders; Rapid Ligation Kits for Cloning or splicing DNA comprising ligase, ATP, and buffers; Cells, Restriction enzymes used for * cutting * DNA; Restriction endonucleases used for cutting DNA; RNA from specific tissue; Diethyl Pyrocarbonate Treated Water; Thermostable Reverse Transcriptase for making cDNA; Ribonuclease Inhibitors for preventing proteins from degrading RNA; Reverse Transcriptase Kits for purifying cDNA comprising buffers, reverse transcriptase and primers for allowing copying of RNA into DNA; Modifying Enzymes for modifying DNA; DNA Labelling Kits comprising DNA polymerase, Random Hexamers, Nucleotide Mixes and Reaction Buffers for allowing downstream identification of DNA; Plasmid Purification Spin Kits for purifying plasma DNA comprising resins, centrifuge tubes or containers, and buffers for allowing isolation of plasma DNA from bacteria. Genomic DNA Spin Kits comprising resins, centrifuge tubes or containers, and buffers for allowing isolation of DNA from cells; DNA Blood Spin Kits comprising resins, centrifuge tubes or containers, and buffers for * allowing * isolation of DNA from blood; DNA or RNA Isolation Kits for extracting genomic DNA or RNA from whole blood, blood lymphocytes, cultured cells or tissues, comprising resins, columns and buffers for allowing isolation of DNA or RNA from cells or tissue; Kits for Recovering DNA fragments from gels or solutions comprising resins and buffers for isolating DNA from agrose gel; Kits for purification of PCR products or DNA comprising PCR assay, buffers and spin filters for isolating DNA from Polymerase Chain Reactions; Spin columns for isolating DNA or RNA; Kits for isolating RNA free of genomic DNA comprising resins, columns and buffers for allowing isolation of RNA from cells or tissue; Kits for isolating RNA from a variety of samples comprising resins, columns and buffers for allowing isolation of RNA from cells or tissue; Kits for isolating RNA from plant material comprising resins, columns, and buffers for allowing isolation of RNA from plant tissue; and Reagents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2010 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| May 20, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 20, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 22, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2009 | NWAP | NEW APPLICATION ENTERED | — |